Our study also demonstrated that the presence of GOF mutations in PIK3CD does not impair BCR-induced AKT, mTOR and S6 phosphorylation, rendering this assay a very helpful confirmatory diagnostic test for APDS in the differential diagnosis from other CVID patients. Here, RPS6 is linked to activated PI3K-delta syndrome.